Dr. Elena Marisol Herrera, Co‑Founder & Chief Medical Officer
Credentials: MD (University of Barcelona), PhD in Clinical Pharmacology (Karolinska Institutet), Fellow of the European Society of Internal Medicine | Spain
Clinic: Valencia Precision Health Institute, Valencia, Spain
Bio:
Dr. Elena Marisol Herrera boasts over 18 years of experience in clinical pharmacology and internal medicine. After earning her MD from the University of Barcelona, she completed a PhD at Karolinska Institutet, where her work on targeted drug delivery earned the Nordic Early Career Research Award in 2019. She later led multicenter trials on novel anticoagulants across four EU countries. A passionate advocate for patient‑centered care, Dr. Herrera founded the Valencia Precision Health Institute to pioneer biomarker‑driven treatment protocols. As Chief Medical Officer, she defines our clinical roadmap, regulatory strategy, and ensures that every therapy we develop adheres to the highest standards of safety, efficacy, and compassion.
Dr. Aurelia Simone Novak, Co‑Founder & Chief Health Economist
Credentials: MD (Charles University), MSc in Health Economics (London School of Economics), Certified Board Member (European Healthcare Board) | Czech Republic
Clinic: Central European Health Analytics Hub, Prague, Czech Republic
Bio:
Dr. Aurelia Simone Novak combines clinical insight with rigorous economic analysis to optimize healthcare delivery. She earned her MD at Charles University before completing an MSc in Health Economics at the LSE, where her dissertation on value‑based care models won the European Health Economics Excellence Prize in 2022. As Principal Health Economist for the Prague Regional Health Authority, she designed reimbursement frameworks that reduced system costs by 12% while improving patient outcomes. Dr. Novak has been invited to advise the European Commission on cross‑border healthcare financing. In her role, she crafts our market‑access strategies, payer engagement plans, and value‑demonstration studies, ensuring our solutions are not only clinically transformative but also economically sustainable worldwide.